Home » COST-CONTAINMENT STRATEGIES RESTRICT INNOVATION -- FROST & SULLIVAN
COST-CONTAINMENT STRATEGIES RESTRICT INNOVATION -- FROST & SULLIVAN
Cost containment and the rationalisation of medical resources are the two major
prevailing trends in the European medical devices industry today. This is largely
due to increasing cost pressures facing the industry as a result of diminishing
healthcare budgets.
PRnewswire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May